AI Earnings Predictions for Fortrea Holdings Inc. (FTRE)

EX-99.1

2 exhibit991-pressreleasedat.htm

EX-99.1

Document

Exhibit 99.1

Fortrea Reports Third Quarter 2026 Results

Sustained commercial momentum, continued margin improvement, and targeted investments strengthen growth foundation

Highlights

For the three months ended September 30, 2026:

•Revenues of $691.5 million

•Book-to-bill ratio of 1.12x, resulting in 1.12x book-to-bill for the trailing 12 months

•GAAP net income of $0.6 million, or $0.01 per diluted share

•Adjusted EBITDA of $58.0 million

•Adjusted net income of $27.9 million, or $0.28 per diluted share

•Cash provided by operations of $60.8 million and free cash flow of $52.5 million

•Raised midpoints of full-year revenue and adjusted EBITDA guidance and narrowed ranges

DURHAM, N.C., October 29, 2026— Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today reported financial results for the third quarter ended September 30, 2026.

“Fortrea delivered another quarter of progress on our return-to-growth strategy, reflecting stronger commercial execution, continued operational improvements and financial discipline,” said Anshul Thakral, CEO of Fortrea. “Our sustained bookings momentum is building a foundation for growth, while targeted investments in early clinical development and technology enhance our ability to deliver differentiated value to clients. I’m proud of how Fortrea’s teams around the world are embracing our future direction while delivering for clients today. Our continued execution against our priorities gives us confidence to raise the midpoints of full-year guidance while narrowing ranges. We remain focused on translating stronger demand into revenue growth, margin expansion and long-term shareholder value.”

Third Quarter 2026 Financial Results

Revenue for the third quarter was $691.5 million, compared to $701.3 million in the third quarter of 2025.

Third quarter GAAP net income was $0.6 million and diluted income per share was $0.01, compared to third quarter of 2025 GAAP net loss of $(15.9) million and diluted loss per share of $(0.17). Third quarter adjusted net income was $27.9 million and adjusted diluted EPS was $0.28, compared to third quarter of 2025 adjusted net income of $11.7 million and adjusted diluted EPS of $0.12. Third quarter adjusted EBITDA was $58.0 million, compared to third quarter of 2025 adjusted EBITDA of $50.7 million.

During the third quarter, the Company performed a detailed review of contracts included in its backlog. As a result, the Company reduced backlog by $558 million to reflect the cumulative impact of estimated scope and study delivery requirements across customer contracts, including inactive trials. The adjustment has no impact on historical financial results, previously issued or current 2026 guidance, or near-term revenue estimates. Backlog, as adjusted, as of September 30, 2026, was $7,316 million. The book-to-bill ratio, which was not impacted by the adjustment, was 1.12x for the quarter.

Year-to-Date 2026 Financial Results

Year-to-date revenue was $2,006.2 million, compared to $2,062.9 million in the same period of 2025.

Year-to-date GAAP net loss was $(36.2) million and diluted loss per share was $(0.38), compared to net loss of $(953.7) million and diluted loss per share of $(10.53), inclusive of a non-cash goodwill impairment charge of $797.9 million, for the same period of 2025. Year-to-date adjusted net income was $65.8 million and adjusted diluted EPS was $0.66, compared to adjusted net income of $31.2 million and adjusted diluted EPS of $0.34 for the same period of 2025. Year-to-date adjusted EBITDA was $163.7 million, compared to adjusted EBITDA of $135.9 million for the same period of 2025.

2026 Financial Guidance

The Company updated its full-year 2026 guidance, narrowing the revenue and adjusted EBITDA ranges and raising both midpoints. The Company now expects revenues of $2,665 million to $2,690 million and adjusted EBITDA of $210 million to $218 million.

Earnings Call and Replay

Fortrea will host a conference call at 8:00 am ET on October 29, 2026, to review its third quarter financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea website. A supplemental slide presentation will also be available on the Investor Relations website prior to the start of the call.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology,

EX-99.1

2 exhibit991-pressreleasedat.htm

EX-99.1

Document

Exhibit 99.1

Fortrea Reports Second Quarter 2026 Results

Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance

Highlights

For the three months ended June 30, 2026:

•Revenues of $678.2 million

•Book-to-bill ratio of 1.06x, resulting in 1.12x book-to-bill for the trailing 12 months

•GAAP net loss of $(13.2) million, or $(0.14) per diluted share

•Adjusted EBITDA of $58.7 million

•Adjusted net income of $22.7 million, or $0.23 per diluted share

•Cash provided by operations of $28.9 million and free cash flow of $19.9 million

•Full-year 2026 guidance increased to revenue of $2,620 million to $2,690 million and adjusted EBITDA of $205 million to $220 million

DURHAM, N.C., July 29, 2026— Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today reported financial results for the second quarter ended June 30, 2026.

"Our second quarter results reflect continued progress against our strategy and disciplined execution across the business," said Anshul Thakral, CEO of Fortrea. "We delivered solid operating and financial performance, including our fourth consecutive quarter with a book-to-bill ratio above 1.0x, and raised our full-year 2026 guidance to reflect our confidence in the business. Underlying this performance is the dedication of our teams around the world, who continue to build trusted partnerships with clients and help advance important therapies for patients. We remain focused on commercial execution, operational excellence and financial discipline as we continue our strategic journey toward sustainable growth and margin expansion."

Second Quarter 2026 Financial Results

Revenue for the second quarter was $678.2 million, compared to $710.3 million in the second quarter of 2025.

Second quarter GAAP net loss was $(13.2) million and diluted loss per share was $(0.14), compared to second quarter of 2025 GAAP net loss of $(374.9) million and diluted loss per share of $(4.14), inclusive of a non-cash goodwill impairment charge of $309.1 million. Second quarter adjusted net income was $22.7 million and adjusted diluted EPS was $0.23 compared to second quarter of 2025 adjusted net income of $17.6 million and adjusted diluted EPS of $0.19. Second quarter adjusted EBITDA was $58.7 million, compared to second quarter of 2025 adjusted EBITDA of $54.9 million.

Backlog as of June 30, 2026 was $7,800 million, and the book-to-bill ratio for the quarter was 1.06x.

First Half 2026 Financial Results

Revenue for the first half was $1,314.7 million, compared to $1,361.6 million in the first half of 2025.

First half GAAP net loss was $(36.8) million and diluted loss per share was $(0.39), compared to first half of 2025 GAAP net loss of $(937.8) million and diluted loss per share of $(10.37), inclusive of a non-cash goodwill impairment charge of $797.9 million. First half adjusted net income was $37.9 million and adjusted diluted EPS was $0.38 compared to first half of 2025 adjusted net income of $19.5 million and adjusted diluted EPS of $0.21. First half adjusted EBITDA was $105.7 million, compared to first half of 2025 adjusted EBITDA of $85.2 million.

2026 Financial Guidance

The Company increased its guidance for the full-year 2026, targeting revenues in the range of $2,620 million to $2,690 million and adjusted EBITDA in the range of $205 million to $220 million.

Earnings Call and Replay

Fortrea will host a conference call at 8:00 am ET on July 29, 2026, to review its second quarter financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea website. A supplemental slide presentation will also be available on the Investor Relations website prior to the start of the call.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1784726519.7ff1d7a

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.